ResMed
From Wikipedia, the free encyclopedia
 |
The creator of or a contributor to this page, ResMed, may have a conflict of interest with the subject of this article. |
| ResMed | |
|---|---|
| Type | Public (NYSE: RMD) |
| Founded | 1989 |
| Headquarters | Poway, California |
| Key people | Peter C. Farrell, Founder and CEO |
| Products | Medical equipment for sleep-disordered breathing and other respiratory disorders |
| Website | www.resmed.com |
ResMed is a manufacturer of products for the treatment of sleep disorders, particularly obstructive sleep apnea.
ResMed was formed in 1989, its primary purpose was to commercialise a device for treating obstructive sleep apnea with nasal continuous positive airway pressure (CPAP). CPAP treatment was commercialised by Peter Farrell and Professor Colin Sullivan.
In March 2007, the company recalled all of its flagship S8 models worldwide due to electrical safety problems.[1]
[edit] See also
[edit] References
- ^ Firm Press Release: ResMed Issues a Voluntary Recall for Certain S8 Flow Generators (html). Food and Drug Administration website (23 April 2007). Retrieved on 2007-06-19. “FOR IMMEDIATE RELEASE -- San Diego, CA, April 23, 2007 — ResMed today announced a worldwide voluntary recall of approximately 300,000 of its early production S8 flow generators used for the treatment of obstructive sleep apnea. In S8 devices manufactured between July 2004 and May 15, 2006, there is a potential for a short circuit in the power supply connector.”
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
